- cafead   May 24, 2024 at 11:52: AM
via Nimbus Therapeutics’ small molecule drug candidate NDI-101150 showed strong potential for clinical benefit in patients with advanced solid tumors, the Boston-based biotech announced on Thursday.
article source
article source